If you are a healthcare startup or a health-tech vendor, you have probably been asked for two things in the same sales cycle: a SOC 2 report and proof of HIPAA compliance. Both expect penetration testing. Many companies respond by commissioning two separate engagements, paying twice, scheduling twice, and pulling their engineering team into remediation twice. That is wasted money and wasted time, because the technical testing underneath both frameworks is almost identical.
This article explains where SOC 2 and HIPAA overlap, why a single, well-scoped penetration test can satisfy both, and how Redfox Cybersecurity structures one engagement and one report to serve both your SOC 2 auditor and your HIPAA risk analysis. For a growing company trying to close enterprise and healthcare deals at the same time, consolidating SOC 2 HIPAA penetration testing into one engagement is one of the easier wins available.
The two frameworks answer different questions for different audiences, which is why buyers often ask for both.
SOC 2, governed by the AICPA Trust Services Criteria, is what enterprise customers and their procurement teams ask for before they trust you with their data. It is an attestation, produced by a licensed CPA firm, that your controls meet criteria across security and, where relevant, availability, confidentiality, processing integrity, and privacy. The security category, known as the Common Criteria, is mandatory in every SOC 2 report.
HIPAA is law, not a voluntary attestation. If you create, receive, maintain, or transmit protected health information (PHI) as a covered entity or a business associate, the HIPAA Security Rule requires you to protect it. That includes conducting an accurate and thorough risk analysis and implementing safeguards to reduce risk to a reasonable level. Your healthcare customers will ask you to sign a Business Associate Agreement and will often ask for evidence that you test your defenses.
A healthcare SaaS company selling into hospitals typically needs both at once: SOC 2 to clear enterprise security review, and HIPAA compliance because PHI is in scope. The good news is that the penetration testing both expect is substantially the same work.
SOC 2 does not contain a line item that literally says "perform a penetration test." However, the Common Criteria expect you to identify and address vulnerabilities, and in practice auditors treat penetration testing as the standard evidence that you do. Criterion CC4.1 covers monitoring of controls, and CC7.1 covers detecting and evaluating vulnerabilities. Most auditors expect to see a recent penetration test report as part of that evidence, and many enterprise customers require one regardless of what the auditor asks.
HIPAA is similar in spirit. The Security Rule does not use the words "penetration test" either, but its risk analysis requirement at 164.308(a)(1) and its technical safeguards at 164.312 are difficult to satisfy convincingly without one. A penetration test is among the strongest forms of evidence that your risk analysis reflects real-world exposure rather than a paper exercise.
The clearest overlap is in access control, and it is worth looking at closely because it is where most penetration test findings land.
Common Criterion CC6.1 requires the organization to implement logical access security software, infrastructure, and architectures over protected information assets to protect them from security events. In practice, that means identity and access management, authentication, authorization, network segmentation, and encryption of data at rest and in transit.
HIPAA's technical safeguards map almost one to one onto CC6.1:
When a penetration tester finds broken access control, a weak authentication flow, or unencrypted data in transit, that single finding is simultaneously a CC6.1 gap and a HIPAA 164.312 gap. You do not need two tests to discover it, and you do not need two reports to describe it. Our HIPAA penetration testing is designed to produce findings mapped to both frameworks from the outset, so one assessment feeds both compliance tracks.
The reason a single engagement works is that penetration testing targets the system, not the framework. An attacker does not care whether your access control is labeled CC6.1 or 164.312(a). They look for the same weaknesses either way, so the testing methodology is identical. The frameworks differ only in how findings are documented and mapped.
The difference is in presentation. A consolidated report documents each finding once, with reproduction steps and remediation, then provides two mapping layers: one to the SOC 2 Trust Services Criteria, and one to the HIPAA Security Rule safeguards. Your SOC 2 auditor reads the first mapping, your HIPAA risk analysis consumes the second, and your engineering team fixes each issue a single time.
This is exactly how we structure engagements for healthcare startups. Because we scope the test against both frameworks from the start, the resulting report drops neatly into a SOC 2 evidence request and a HIPAA risk analysis without rework. If your environment includes clinical data or integrations, our healthcare penetration testing adds the healthcare-specific depth, such as PHI data flow mapping, on top of that dual-framework foundation.
The savings come from several places, and they add up quickly for a small team.
Two separate penetration tests mean two scoping efforts, two sets of fieldwork, and two reports. Consolidating into one engagement typically removes a large share of that duplicated cost. The exact figure depends on your environment's size and complexity, so the right way to size it is a scoping call rather than a headline number, but for many startups the saving runs into five figures.
The less obvious cost of two tests is the drain on your own team. Each engagement pulls engineers into scoping calls, access provisioning, and remediation cycles. Running one test means your team provisions access once, sits through one readout, and remediates one prioritized list. For a startup where engineering time is the scarcest resource, that is often worth more than the invoice difference.
A single report that is already mapped to both frameworks shortens both audits. Your SOC 2 auditor is not waiting on a separate healthcare assessment, and your HIPAA risk analysis is not waiting on the SOC 2 test. The compliance calendar compresses, which matters when a customer contract is gated on both.
A consolidated report only saves time if it is built the way auditors expect to consume it. SOC 2 auditors generally look for a few specific things in a penetration test report, and a report that includes them tends to move through review without follow-up questions:
When those elements are present and the findings are mapped to the Trust Services Criteria, the report typically satisfies the auditor's vulnerability-management evidence requirement without a separate request. Adding the HIPAA safeguard mapping alongside it is what makes the same document serve the risk analysis too.
Getting the dual-purpose benefit depends on scoping correctly up front. A test scoped only for SOC 2 may miss healthcare-specific concerns, and a test scoped only for HIPAA may not give the auditor the coverage they expect.
Start by defining the environment that handles sensitive data, whether that data is customer records for SOC 2 purposes, PHI for HIPAA purposes, or both. In most healthcare startups these overlap heavily, so a single well-drawn boundary covers both needs.
Document where sensitive data enters, where it is stored, and where it leaves. This satisfies the SOC 2 expectation to understand your information assets and the HIPAA expectation to know where PHI lives, which is the foundation of a defensible risk analysis.
Decide at scoping time that findings will be mapped to both the Trust Services Criteria and the HIPAA Security Rule. Doing this at the start, rather than retrofitting it after the test, is what lets one report serve both auditors cleanly.
A few missteps can undo the savings, so they are worth avoiding deliberately.
HIPAA has healthcare-specific exposure that generic SOC 2 scoping can miss, such as PHI leaking through an API, an analytics export, or a third-party integration. The test must look for those, not just relabel generic findings. This is why a tester with healthcare experience matters.
HIPAA expects a risk analysis, not just a vulnerability list. The penetration test feeds that analysis, but the findings should be framed in terms of risk to PHI, not only technical severity, so they slot directly into your Security Rule documentation.
A SOC 2 auditor expects coverage of the systems in your described boundary. If the test is scoped too tightly to save money, the auditor may ask for additional testing, which erases the savings. Scope to the real boundary once and test it properly.
This approach fits a specific and common profile: a company that handles PHI and sells to customers who demand SOC 2. That includes healthcare SaaS platforms, digital health and telehealth startups, health-tech vendors integrating with EHRs, and analytics or billing companies that process patient data on behalf of providers. If both a SOC 2 report and a signed Business Associate Agreement show up in your sales conversations, you are a strong candidate for a single, dual-mapped engagement.
If only one framework currently applies to you, a combined test may be premature, but it is still worth scoping with the future in mind, since a healthcare company that sells to enterprises will almost always end up needing both. Talking through your roadmap during scoping helps avoid paying for a narrow test now and a broader one in six months. Our team can walk through that with you as part of HIPAA penetration testing scoping.
Yes, when it is built for both. The penetration test itself is the same technical work. A report that documents each finding once and maps it to both the Trust Services Criteria and the HIPAA Security Rule gives each reviewer what they need. The key is agreeing that dual mapping at scoping time rather than trying to retrofit it afterward.
Yes. Combining the penetration test does not merge the two programs. You still undergo a SOC 2 audit with your CPA firm and still maintain your own HIPAA risk analysis and documentation. What you save is the duplicated penetration testing that would otherwise feed each one separately.
Most SOC 2 auditors expect a test within the last twelve months, and many healthcare customers expect annual testing as well. Running one combined test each year, plus a retest after major changes, keeps both tracks current on the same cadence.
The same consolidated approach extends. Because HITRUST and other frameworks draw heavily on the same access-control and vulnerability-management expectations, a penetration test already mapped to SOC 2 and HIPAA is a strong starting point that can be mapped further with limited extra work.
For a healthcare startup juggling enterprise security reviews and HIPAA obligations at the same time, running one penetration test instead of two is a straightforward way to save money and move faster without cutting corners on either framework. Redfox Cybersecurity scopes engagements to serve both from the start and delivers a single report your SOC 2 auditor and HIPAA risk analysis can both use. To see how it would map to your environment, talk to us about HIPAA penetration testing or broader healthcare penetration testing.
Redfox Cyber Security Inc.
8 The Green, Ste. A,
Dover, Delaware 19901,
United States.
.avif)
